Insider buying last 90 days
No open-market insider purchases were filed for BOW in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Bowhead Specialty's week was framed by a single piece of coverage examining behavioral patterns and institutional flows in the stock, which described a neutral near- and mid-term outlook alongside a longer-term positive bias. No earnings, guidance, deal or regulatory news accompanied the move, leaving sentiment analysis as the main talking point for the period.
The stock closed at $34.02, essentially flat on the day, sitting above both its 50-day average of $33.69 and its 200-day average of $28.02, with the shorter average also above the longer one. It trades near its 52-week high of $35.07 and well above its 52-week low of $21.21, with returns of 1% over one month, 10.3% over three months, 38.8% over six months and 31% over one year. The GekkoIndex reads 51.1, placing BOW in the Neutral zone, and the price sits about 0.5% above Gekko Fair Value of $33.86.
Bowhead Specialty's next earnings report is set for 3 November 2026, 21 days out, falling inside a typical 20-trading-day holding window; its last report showed EPS of $0.47 against an estimate of $0.45, with a 5.5% reaction. No insider, Congress or unusual options activity appears in the respective 90-day and 30-day windows, and no seasonal history is available. Analyst coverage from 6 firms is uniformly rated hold, with a consensus target of $34.33, implying 0.9% upside to current levels.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Bowhead Specialty scores 1 supportive, 2 mixed and 1 headwind across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive2 mixed1 headwind
Above 50 and 200-day
Close $34.02 is above the 50-day ($33.69) and 200-day ($28.02) averages, and the 50-day is above the 200-day.
See the chart51.1, Neutral
Reading 51.1 is in the Neutral zone.
See the GekkoIndex0.5% above
Price is within 5% of Gekko Fair Value (0.5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 22 days
Reports on Nov 3, 2026, 22 days away — inside a typical 20-trading-day hold.
See earningsNo data
Not enough years of history for a seasonal read.
A description of current data, not a recommendation. How this page works
Bowhead Specialty closed at $34.02 on Oct 12, 2026, +31.0% over the past year, inside a 52-week range of $21.21 to $35.07.
Use the left and right arrow keys to read daily values.
Put BOW on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Bowhead Specialty’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 51.1, in the Neutral zone, down 1.7 points over five sessions.
Down 1.7 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 11 | −0.3% | −5.6% | ||
| Accumulation | 226 | +0.2% | +0.2% | ||
| Neutral (current zone) | 316 | +0.2% | +2.6% | ||
| Distribution | 39 | +2.8% | +0.6% | ||
| Selling | 0 | Not available | |||
Average BOW share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Bowhead Specialty trades 0.5% above Gekko Fair Value of $33.86, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Bowhead Specialty shares are worth, recalculated every trading day.
$33.86
Gekko Fair Value, Oct 9, 2026
0.5% above fair value · About fair value
At the end of Aug 2026 the price was 0.0% above the estimate.
No open-market insider purchases were filed for Bowhead Specialty, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for BOW in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in BOW were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Bowhead Specialty has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold BOW.
Bowhead Specialty reports on Nov 3, 2026 (22 days away), and beat the EPS estimate in 7 of its last 7 reports.
Nov 3, 2026
22 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Feb 24, 2026 | $0.47 est $0.45 | $224.1M est $216.7M | +5.5% |
| Nov 4, 2025 | $0.47 est $0.40 | $143.9M est $146.0M | +6.4% |
| Aug 5, 2025 | $0.37 est $0.36 | $133.3M est $142.0M | −1.0% |
| May 6, 2025 | $0.34 est $0.33 | $122.7M est $133.2M | −6.4% |
| Feb 27, 2025 | $0.40 est $0.33 | $119.4M est $115.1M | +1.7% |
| Nov 5, 2024 | $0.38 est $0.35 | $116.8M est $164.8M | +5.1% |
| Aug 8, 2024 | $0.28 est $0.25 | $98.87M est $94.28M | −0.4% |
| May 29, 2024 | $0.22 | — | −1.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Bowhead Specialty is $34.33, +0.9% from the last close, from 6 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 6 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 10 | Citizens JMP | — | — |
| Aug 24 | J.P. Morgan | $34 | −0.1% |
| Aug 19 | Morgan Stanley | $34 | −0.1% |
| Aug 19 | Morgan Stanley | $34 | −0.1% |
| Aug 4 | Deutsche Bank | $34 | −0.1% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Bowhead Specialty’s market cap is $1.12B, with a P/E ratio of 18.3 and revenue of $615.2M over the last twelve months.
1 headline about Bowhead Specialty from the past week, newest first, each linking to the publisher.
Bowhead Specialty’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGRProgressive | Neutral | 0.6% below |
| MFCManulife Financial | Accumulation | 7.6% above |
| METMetLife | Neutral | 0.6% below |
| ALLAllstate | Accumulation | 9.9% below |
| AFLAFLAC | Neutral | 1.5% below |
| SLFSun Life Financial | Accumulation | 5.2% above |
A peer links to its own page where one exists.
Bowhead Specialty’s market cap is $1.12B at the Oct 12, 2026 close of $34.02, with 32.94M shares outstanding. The shares trade on a P/E ratio of 18.3.
The consensus analyst 12-month price target for Bowhead Specialty is $34.33, +0.9% from the last close. Of the 6 firms that rated the stock in the last 90 days, 0 rate it a buy, 6 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Bowhead Specialty is about fair value: the Oct 12, 2026 close of $34.02 is 0.5% above Gekko Fair Value of $33.86. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Bowhead Specialty is expected to report on Nov 3, 2026 (22 days away). Analysts expect earnings of $0.51 per share on revenue of $278.6M. Bowhead Specialty beat the earnings estimate in 7 of its last 7 reports, moving 3.5% on average across the report.
Bowhead Specialty’s 52-week high is $35.07 and its 52-week low is $21.21; it closed at $34.02 on Oct 12, 2026, +31.0% over the past year. Over the last five years the shares peaked at $42.29 on Mar 28, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 4 items with data read as supportive (trend), 2 as mixed (gekkoindex and fair value) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.